Tecan

TECN.SWPre-clinical

Männedorf, SwitzerlandFounded 1980tecan.com

Tecan is a Swiss public company empowering customers to scale healthcare innovation globally through laboratory automation and digitization. It serves a broad market across life sciences, applied markets, and clinical diagnostics with a comprehensive portfolio of instruments, consumables, software, and services. With a focus on enabling next-generation sequencing, genomics, drug discovery, and diagnostic testing, Tecan is a critical partner for research and clinical laboratories worldwide.

Market Cap

$1.9B

Founded

1980

Employees

2000-5000

Focus

DiagnosticsProteomics

TECN.SW · Stock Price

USD 116.10235.10 (-66.94%)

Historical price data

AI Company Overview

Technology Platform

Provider of laboratory automation and digitization solutions, including liquid handling workstations, microplate readers, and integrated software, designed to automate and streamline complex workflows in research and diagnostics.

Funding History

IPOUndisclosedUndisclosedJun 15, 1998

Opportunities

Growth is driven by the expansion of genomics and personalized medicine requiring advanced sample prep, increased biopharma R&D investment, the global trend towards laboratory digitization, and the need for automation in clinical diagnostics to improve efficiency and throughput.

Risk Factors

Key risks include sensitivity to cyclical biopharma R&D spending, intense competition from large instrument companies, potential supply chain disruptions for critical components, and exposure to foreign exchange fluctuations due to global operations.

Competitive Landscape

Tecan competes with major players like PerkinElmer, Agilent, Beckman Coulter (Danaher), Hamilton, and Eppendorf. It differentiates through a broad portfolio spanning instruments and software, a strong focus on workflow integration, and a global service network supporting both life sciences and diagnostics customers.

Publications

Patents